The Emerging Risk of Peptides in Supplements LegitScript BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS